Vireo Growth Inc. reports Q3 revenue increase driven by asset acquisitions
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
Vireo Growth Inc. reported third fiscal quarter GAAP revenue of $253.7 million, marking a 177% increase year-over-year. This growth was driven by acquisitions, including certain PharmaCann Colorado assets and Cannabist Colorado assets. Proforma revenue for the quarter reached $277.0 million.
Why it matters
The company's consolidation strategy, which included significant acquisitions, resulted in an annualized revenue run rate exceeding $1 billion based on third quarter GAAP revenue. Vireo also expanded its financing capacity with new banking partners and launched a share repurchase program.
Who's involved
- MSACzech company that previously operated the German business which is currently being exited
- Julie BeckGerman association football player who serves as the Chief Financial Officer of MSA
- Moussa Ag AcharatoumaneAzawadi spokesperson who serves as the leader of MSA
- Theravance Biopharma (United States)United States company actively developing therapies targeting MSA patients
- SSP GroupMultinational foodservice company that previously operated the German MSA business
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- MSASpeculative
MSA might see changes in ownership or control due to the acquisition of valuable assets.
Keep exploring
The entities involved
-
MSA
Czech company
Nothing else this week.